CURE’s breast cancer page is an extensive resource of cancer information featuring the latest breast cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on breast cancer.
June 1st 2025
Camizestrant and continued therapy with CDK4/6 inhibition benefits patients who present with ESR1-mutated, ER+, HER2– advanced breast cancer.
Evolving Paradigm of TNBC Means One-Size-Fits All No Longer Applies to Treatment
November 1st 2022Over the past 20 years, chemotherapy has remained the primary treatment for triple-negative breast cancer. However, recent advancements have shown that a one-size-fits all treatment approach no longer works.